An Exploratory Study to Investigate the Immunomodulatory Activity of Various Dose Levels of Anti Programmed-Deach-1 (PD-1) Antibody (BMS-936558) in Subjects with Metastatic Clear Cell Renal Cell Carcinoma (RCC)
Renal Cell Carcinoma | Renal Cell Carcinoma (RCC)
What is the purpose of this trial?
- 18 Years and older
Click here for detailed information about who can participate in this trial.
- Bristol-Myers Squibb
- July 2011
- Last Updated:
- Study HIC#: